{"id":"W4387060869","doi":"10.1007/s13555-023-01017-8","title":"Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA","year":2023,"lang":"en","type":"letter","venue":"Dermatology and Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Secukinumab; Discontinuation; Ixekizumab; Medicine; Adalimumab; Psoriasis; Dermatology; Dosing; Internal medicine; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004275506,0.0007269082,0.001945989,0.0007436026,0.002409813,0.002718446,0.002096075,0.03448826,0.004853367],"category_scores_gemma":[0.02807521,0.0006153414,0.00122498,0.001049844,0.001554293,0.002638742,0.0008136472,0.02875137,0.004168469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003592619,"about_ca_system_score_gemma":0.004162963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004311446,"about_ca_topic_score_gemma":0.006928043,"domain_scores_codex":[0.9966608,0.001025599,0.0005639853,0.0005042804,0.0008899894,0.0003553401],"domain_scores_gemma":[0.9864694,0.007273501,0.00091164,0.0003355817,0.003272737,0.001737262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005442062,0.00003737785,0.000626218,0.00005226726,0.00001414392,0.001111915,0.00006612156,0.00004667355,0.00008185349,0.0004778072,0.9931383,0.004292837],"study_design_scores_gemma":[0.0002504426,0.0001821572,0.004656257,0.0007652524,0.00008616791,0.005376296,0.0006990298,0.001670573,0.0005679245,0.005071587,0.9805406,0.0001337467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0005214222,0.0006421718,0.00009520408,0.9743634,0.02315943,0.00001522732,0.0001108633,0.0000317381,0.00106062],"genre_scores_gemma":[0.005999016,0.000771715,0.0003068432,0.9292948,0.0597106,0.00004506496,0.00004715975,0.0000417324,0.003782929],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03448826,"threshold_uncertainty_score":0.02606642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.157956019820155,"score_gpt":0.3788201942551079,"score_spread":0.2208641744349528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}